Poland withdraws all batches of antidepressant Dutolox over carcinogen impurity

Polish authorities have withdrawn all batches of the antidepressant Dutolox after detecting levels of a carcinogenic impurity more than double the European Medicines Agency's permissible limit. The action follows a pattern of nitrosamine-related recalls across pharmaceuticals, but this is a specific regulatory action affecting a single product. The health risk to patients is uncertain, and the impact is limited to the Polish market.